Cargando…
High Expression of Triggering Receptor Expressed on Myeloid Cells 1 Predicts Poor Prognosis in Glioblastoma
BACKGROUND: Glioblastoma (GBM) is a highly malignant tumor with poor prognosis, and new treatment strategies are urgently needed. Currently, the role of triggering receptor expressed on myeloid cells 1 (TREM-1) in tumors has been studied, but the role of TREM-1 in GBM remains unclear. METHODS: Immun...
Autores principales: | Ma, Ke, Guo, Qianqian, Zhang, Xianwei, Li, Yanxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238274/ https://www.ncbi.nlm.nih.gov/pubmed/37274309 http://dx.doi.org/10.2147/OTT.S407892 |
Ejemplares similares
-
Identification of HOXD10 as a Marker of Poor Prognosis in Glioblastoma Multiforme
por: Li, Yanxin, et al.
Publicado: (2021) -
High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas
por: Si, Daolin, et al.
Publicado: (2020) -
High Expression of VAV Gene Family Predicts Poor Prognosis of Acute
Myeloid Leukemia
por: Mu, Dan, et al.
Publicado: (2021) -
Elevated RGMA Expression Predicts Poor Prognosis in Patients with Glioblastoma
por: Phan, Thi Le, et al.
Publicado: (2021) -
High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia
por: Song, Ying, et al.
Publicado: (2019)